Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers

BACKGROUND: The aim of this study was to investigate the expression of the nuclear receptor PPARγ, together with that of the cyclooxygenases Cox-1 and Cox-2, in breast cancer (BC) tissues and to correlate the data with several clinicobiological parameters including patient survival. METHODS: In a we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Shao, Wanting, Kuhn, Christina, Mayr, Doris, Ditsch, Nina, Kailuwait, Magdalena, Wolf, Verena, Harbeck, Nadia, Mahner, Sven, Jeschke, Udo, Cavaillès, Vincent, Sixou, Sophie
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7035771/
https://ncbi.nlm.nih.gov/pubmed/32085795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02271-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars